Univercells rakes in $18.8 mln Series B
Univercells SA, a Belgian biotech company, has raised $18.8 million in Series B funding. Global Health Investment Fund led the round.
16 July 2018•1 min read
Univercells SA, a Belgian biotech company, has raised $18.8 million in Series B funding. Global Health Investment Fund led the round.
